Close

Illumina (ILMN) Sinks as Trading Resumes

Go back to Illumina (ILMN) Sinks as Trading Resumes

Canaccord Genuity Cuts Price Target on Illumina (ILMN) to $135 Following Weak 3Q Preannouncement

October 11, 2016 9:53 AM EDT

Canaccord Genuity maintained a Hold rating on Illumina (NASDAQ: ILMN), and cut the price target to $135.00 (from $165.00), following the company's 3Q preannouncement. After the close, ILMN preannounced revenues of ~$607M, ~$21M below the Street's $628M and the $625-630M guide. ILMN did not report adjusted EPS but the revenue shortfall implies EPS of $0.87, below the Street's $0.91 estimate.

Analyst Mark... More

Illumina (ILMN) will resume trading at 4:35pm ET

October 10, 2016 4:10 PM EDT

Illumina (NASDAQ: ILMN) will resume trading at 4:35pm EDT.

... More

Thermo Fisher (TMO), Pacific Bio (PACB) on Watch Following Revenue Warning from Illumina (ILMN)

October 10, 2016 4:09 PM EDT

Thermo Fisher (NYSE: TMO), Pacific Bio (Nasdaq: PACB) on Watch Following Revenue Warning from Illumina (Nasdaq: ILMN)

... More

Illumina (ILMN) Prelim. Q3 Revenue Misses Views; Offers Light Q4 Outlook

October 10, 2016 4:06 PM EDT

(Updated - October 10, 2016 4:18 PM EDT)

Illumina, Inc. (Nasdaq: ILMN) announced estimated third quarter revenue of approximately $607 million, a 10% increase compared to $550 million in the third quarter of 2015. This unaudited estimate, based on management's preliminary financial analysis, is lower than the third quarter revenue guidance of $625 million to $630 million.

(Note: The Street sees revenue of $628.1 million.)

The shortfall in quarterly revenue was driven by a larger than anticipated year-over-year decline in high throughput... More